A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB) in Korean Adult Population
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 28
(1)
◽
pp. 389-398
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 98
(5)
◽
pp. 53
Keyword(s):